CGT
ISEE

Capital Guardian Trust’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Capital Guardian Trust’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65
Closed -$3K – 794
2016
Q1 		$3K Buy
+65
New +$3.31K ﹤0.01% 737

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Guardian Trust's ISEE Position: Q2 2016 in Review

Capital Guardian Trust sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2016, closing a stake of 65 shares — an estimated $3K sold.

Capital Guardian Trust first reported a position in ISEE in Q1 2016 and held it in 1 quarter. The position peaked at $3K in Q1 2016. 182 funds tracked by Wall St. Rank hold ISEE as of Q2 2016.

  • Capital Guardian Trust reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Capital Guardian Trust sold 65 IVERIC bio, Inc. Common Stock shares in Q2 2016, an estimated $3K.
  • Capital Guardian Trust first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Capital Guardian Trust's IVERIC bio, Inc. Common Stock position peaked at $3K in Q1 2016.
  • 182 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.